China is relying on vaccines with lower efficacy rates. Photo: Xinhua
China is relying on vaccines with lower efficacy rates. Photo: Xinhua

Explainer |
How China’s drive to develop its own state-of-the-art Covid vaccine is going

  • The country has not authorised any mRNA vaccines, despite their proven benefits, a move many observers believe is down to the wish to develop its own version
  • Currently a number of candidate vaccines made by Chinese firms are undergoing clinical trials

China is relying on vaccines with lower efficacy rates. Photo: Xinhua
China is relying on vaccines with lower efficacy rates. Photo: Xinhua
READ FULL ARTICLE